MARILYN MILLER: Open Payments
NPI 1609141027 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,241 in 115 payments from 26 companies in 2025. Trend: 2023 $1,088 · 2024 $2,371 · 2025 $2,241
Food & beverage: $2,098Education: $143
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $313 |
| ABBVIE INC. | 21 | $300 |
| GENZYME CORPORATION | 8 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $163 |
| EMD Serono, Inc. | 8 | $159 |
| Biogen, Inc. | 5 | $125 |
| UCB, Inc. | 5 | $120 |
| Gilead Sciences, Inc. | 1 | $98 |
| Ardelyx, Inc. | 4 | $92 |
| Lundbeck LLC | 3 | $79 |
Products named: TREMFYA, DUPIXENT, ENTYVIO, RINVOQ, SKYRIZI, Livdelzi, LEQEMBI, IBSRELA.
Industry payments across TX — which companies pay providers there.
